Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Thijssen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Rheumatology (Oxford, England)|December 16, 2014
Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritisEva Thijssen, Arjan van Caam, Peter M van der Kraan
Plos One|December 7, 2021
Touchscreen-based finger tapping: Repeatability and configuration effects on tapping performanceSoma Makai-Bölöni, Eva Thijssen, Emilie M J van Brummelen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 4, 2023
Treatment Detection and Movement Disorder Society-Unified Parkinson's Disease Rating Scale, Part III Estimation Using Finger Tapping TasksAhnjili ZhuParris, Eva Thijssen, Willem O Elzinga, et al.
Parkinsonism & Related Disorders|April 2, 2022
Safety and pharmacokinetics of multiple dosing with inhalable apomorphine (AZ-009), and its efficacy in a randomized crossover study in Parkinson's disease patientsEva Thijssen, Jonas M den Heijer, David Puibert, et al.
Movement Disorders Clinical Practice|November 7, 2022
A Placebo-Controlled Study to Assess the Sensitivity of Finger Tapping to Medication Effects in Parkinson's DiseaseEva Thijssen, Soma Makai-Bölöni, Emilie van Brummelen, et al.
Clinical and Translational Science|May 7, 2024
Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patientsEva Thijssen, Bert Tuk, Michel Cakici, et al.
Clinical and Translational Science|May 13, 2023
A leucine-rich repeat kinase 2 (LRRK2) pathway biomarker characterization study in patients with Parkinson's disease with and without LRRK2 mutations and healthy controlsMaurits F J M Vissers, Matthew D Troyer, Eva Thijssen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 15, 2022
A Randomized First-in-Human Study With UB-312, a UBITh® α-Synuclein Peptide VaccineHui Jing Yu, Eva Thijssen, Emilie van Brummelen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 20, 2022
A Randomized Trial Assessing the Safety, Pharmacokinetics, and Efficacy During Morning Off of AZ-009Eva Thijssen, Jonas den Heijer, David Puibert, et al.
British Journal of Clinical Pharmacology|February 12, 2021
A randomized single and multiple ascending dose study in healthy volunteers of LTI-291, a centrally penetrant glucocerebrosidase activatorJonas M den Heijer, Annelieke C Kruithof, Guido van Amerongen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Rheumatology (Oxford, England)|December 16, 2014
Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritisEva Thijssen, Arjan van Caam, Peter M van der Kraan
Plos One|December 7, 2021
Touchscreen-based finger tapping: Repeatability and configuration effects on tapping performanceSoma Makai-Bölöni, Eva Thijssen, Emilie M J van Brummelen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 4, 2023
Treatment Detection and Movement Disorder Society-Unified Parkinson's Disease Rating Scale, Part III Estimation Using Finger Tapping TasksAhnjili ZhuParris, Eva Thijssen, Willem O Elzinga, et al.
Parkinsonism & Related Disorders|April 2, 2022
Safety and pharmacokinetics of multiple dosing with inhalable apomorphine (AZ-009), and its efficacy in a randomized crossover study in Parkinson's disease patientsEva Thijssen, Jonas M den Heijer, David Puibert, et al.
Movement Disorders Clinical Practice|November 7, 2022
A Placebo-Controlled Study to Assess the Sensitivity of Finger Tapping to Medication Effects in Parkinson's DiseaseEva Thijssen, Soma Makai-Bölöni, Emilie van Brummelen, et al.
Clinical and Translational Science|May 7, 2024
Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patientsEva Thijssen, Bert Tuk, Michel Cakici, et al.
Clinical and Translational Science|May 13, 2023
A leucine-rich repeat kinase 2 (LRRK2) pathway biomarker characterization study in patients with Parkinson's disease with and without LRRK2 mutations and healthy controlsMaurits F J M Vissers, Matthew D Troyer, Eva Thijssen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 15, 2022
A Randomized First-in-Human Study With UB-312, a UBITh® α-Synuclein Peptide VaccineHui Jing Yu, Eva Thijssen, Emilie van Brummelen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 20, 2022
A Randomized Trial Assessing the Safety, Pharmacokinetics, and Efficacy During Morning Off of AZ-009Eva Thijssen, Jonas den Heijer, David Puibert, et al.
British Journal of Clinical Pharmacology|February 12, 2021
A randomized single and multiple ascending dose study in healthy volunteers of LTI-291, a centrally penetrant glucocerebrosidase activatorJonas M den Heijer, Annelieke C Kruithof, Guido van Amerongen, et al.
Pageof 1